Join
Live feed
·
INSIDERFilingvia Quantisnow
Vistagen Therapeutics Inc. logo

Chief Operating Officer Prince Joshua S. was granted 2,671 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VTGN· Vistagen Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTGN (Vistagen Therapeutics Inc.) and more on Quantisnow.